» Articles » PMID: 36054093

Tachycardia in Hyperthyroidism: Not So Common

Overview
Journal PLoS One
Date 2022 Sep 2
PMID 36054093
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The commonly held association of hyperthyroidism with sinus tachycardia and widened pulse pressure (PP) has not been reassessed in decades despite patients with hyperthyroidism in current practice not always present with these signs. The study objective was to assess prevalence and variability of sinus tachycardia and widened PP in present day among individuals with different degrees of hyperthyroidism.

Methods: Data was collected retrospectively from 248 adult patients in an outpatient setting with biochemical evidence of hyperthyroidism, recorded heart rate (HR) and blood pressure (BP) who were not treated with medications that can influence these parameters.

Results: Mean age was 42.0 ± 14.2 years with 66.9% being female. Median free thyroxine (fT4) level was 3.49 (IQR 2.42-4.58) ng/dL and thyroid stimulating hormone (TSH) 0.02 (IQR 0.01-0.03) mIU/L. Tachycardia, defined as HR >100 bpm, was present in 28.2%. In the lowest and highest fT4 quartiles, tachycardia was present in 16.4% and 38.7% respectively. Using logistic regression, tachycardia was associated with higher fT4 and diastolic BP. More lenient outcome of tachycardia with HR >90 bpm was seen in 47.2%. Widened PP, defined as >50 mmHg, was observed in 64.1% of patients and correlated with higher fT4 and BP.

Conclusions: Tachycardia is not a common feature of hyperthyroidism today. The relatively infrequent finding of tachycardia in this study compared to older studies may reflect differences in the way medicine is practiced today. The increased ordering of thyroid function tests most likely unmasked cases of mild or asymptomatic thyrotoxicosis. A widened PP was a more prevalent clinical finding in this study.

Citing Articles

Thyrotoxicosis Misdiagnosed as Long Covid by Telemedicine - A Cautionary Tale.

Sawamura T, Karashima S, Kometani M, Ohmori A, Yoneda T Eur J Case Rep Intern Med. 2024; 11(2):004206.

PMID: 38352809 PMC: 10860905. DOI: 10.12890/2024_004206.

References
1.
Bohm M, Schumacher H, Teo K, Lonn E, Mahfoud F, Mann J . Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Eur Heart J. 2018; 39(33):3105-3114. DOI: 10.1093/eurheartj/ehy287. View

2.
Konrady A . [T3-thyrotoxicosis: incidence, significance and correlation with iodine intake]. Orv Hetil. 2000; 141(7):337-40. View

3.
Klein I, Ojamaa K . Thyrotoxicosis and the heart. Endocrinol Metab Clin North Am. 1998; 27(1):51-62. DOI: 10.1016/s0889-8529(05)70297-8. View

4.
Trivalle C, Doucet J, Chassagne P, Landrin I, Kadri N, Menard J . Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc. 1996; 44(1):50-3. DOI: 10.1111/j.1532-5415.1996.tb05637.x. View

5.
Shahangian S, Alspach T, Rex Astles J, Yesupriya A, Dettwyler W . Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010. Arch Pathol Lab Med. 2013; 138(2):189-203. PMC: 4698806. DOI: 10.5858/arpa.2013-0149-OA. View